The abstract is read at the publisher; the summary is JClub's.
A self-inactivating lentiviral ex vivo vector restoring p47phox in p47phox-deficient mice achieves sustained myeloid NADPH oxidase function with ~80% blood granulocytes at ~2 integrations per cell.
- Why it matters: Chronic granulomatous disease causes recurrent infections and inflammation due to defective phagocyte antimicrobial activity, and durable, safe gene correction is needed for translation.
- What they did: The vector expresses p47phox from the myeloid-specific miR223 promoter; in p47phox-deficient mice it was tested for stem-cell engraftment, long-term myeloid expression/function, biodistribution, and toxicity, and in human cells for NADPH oxidase restoration.
- The result: In mice, ~2 vector integrations per cell restored p47phox expression and NADPH oxidase activity in ~80% of blood granulocytes, with physiological biodistribution and no transgene-related toxicity; in human cells, ~2 integrations restored activity in ~40% of in vitro phagocytes, supporting a first-in-human trial.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.